The Onconeural Antigen cdr2 Is a Novel APC/C Target that Acts in Mitosis to Regulate C-Myc Target Genes in Mammalian Tumor Cells

Kevin J. O'Donovan, Jennifer Diedler, Graeme C. Couture et al. · 2010

Read The Onconeural Antigen cdr2 Is a Novel APC/C Target that Acts in Mitosis to Regulate C-Myc Target Genes in Mammalian Tumor Cells by Kevin J. O'Donovan, Jennifer Diedler, Graeme C. Couture et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010045.txt.

Description

Kevin J O'Donovan and colleagues examine a tumor protein called cdr2 in a 2010 PLOS ONE article. The protein is normally found in some nerve cells, but breast and ovarian tumors make it too. Immune attacks on it can damage the brain's balance center in some patients.

In tumor cells, cdr2 levels peaked while cells divided, then a cell machine tagged it for quick shredding as division ended. Cdr2 also partners with c-myc, a well-known cancer gene driver, to switch on its target genes during division. Removing cdr2 warped the division spindle and slowed growth, while extra cdr2 sped it. The authors see new drug target options for women's cancers.

Catalog record

CREATORKevin J. O'Donovan, Jennifer Diedler, Graeme C. Couture et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010045

Browse the full library · About the Tower of Babel